Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment

JC. Higareda-Almaraz, JS. Ruiz-Moreno, J. Klimentova, D. Barbieri, R. Salvador-Gallego, R. Ly, IA. Valtierra-Gutierrez, C. Dinsart, GA. Rabinovich, J. Stulik, F. Rösl, B. Rincon-Orozco,

. 2016 ; 16 (-) : 680. [pub] 20160824

Language English Country Great Britain

Document type Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't

BACKGROUND: Galectin-7 (Gal-7) is negatively regulated in cervical cancer, and appears to be a link between the apoptotic response triggered by cancer and the anti-tumoral activity of the immune system. Our understanding of how cervical cancer cells and their molecular networks adapt in response to the expression of Gal-7 remains limited. METHODS: Meta-analysis of Gal-7 expression was conducted in three cervical cancer cohort studies and TCGA. In silico prediction and bisulfite sequencing were performed to inquire epigenetic alterations. To study the effect of Gal-7 on cervical cancer, we ectopically re-expressed it in the HeLa and SiHa cervical cancer cell lines, and analyzed their transcriptome and SILAC-based proteome. We also examined the tumor and microenvironment host cell transcriptomes after xenotransplantation into immunocompromised mice. Differences between samples were assessed with the Kruskall-Wallis, Dunn's Multiple Comparison and T tests. Kaplan-Meier and log-rank tests were used to determine overall survival. RESULTS: Gal-7 was constantly downregulated in our meta-analysis (p < 0.0001). Tumors with combined high Gal-7 and low galectin-1 expression (p = 0.0001) presented significantly better prognoses (p = 0.005). In silico and bisulfite sequencing assays showed de novo methylation in the Gal-7 promoter and first intron. Cells re-expressing Gal-7 showed a high apoptosis ratio (p < 0.05) and their xenografts displayed strong growth retardation (p < 0.001). Multiple gene modules and transcriptional regulators were modulated in response to Gal-7 reconstitution, both in cervical cancer cells and their microenvironments (FDR < 0.05 %). Most of these genes and modules were associated with tissue morphogenesis, metabolism, transport, chemokine activity, and immune response. These functional modules could exert the same effects in vitro and in vivo, even despite different compositions between HeLa and SiHa samples. CONCLUSIONS: Gal-7 re-expression affects the regulation of molecular networks in cervical cancer that are involved in diverse cancer hallmarks, such as metabolism, growth control, invasion and evasion of apoptosis. The effect of Gal-7 extends to the microenvironment, where networks involved in its configuration and in immune surveillance are particularly affected.

Department Biologie 2 Ludwig Maximilians Universität München Planegg Martinsried Germany

Department of Molecular Pathology and Biology Faculty of Military Health Sciences University of Defense 500 01 Hradec Králové Czech Republic

Division of Tumor Virology German Cancer Research Center 69 120 Heidelberg Germany

Division of Viral Transformation Mechanisms German Cancer Research Center 85764 Neuherberg Germany

Division of Viral Transformation Mechanisms German Cancer Research Center Im Neuenheimer Feld 242 69120 Heidelberg Germany

Division of Viral Transformation Mechanisms German Cancer Research Center Im Neuenheimer Feld 242 69120 Heidelberg Germany Department of Internal Medicine Infectious Diseases and Respiratory Medicine Charité 10117 Berlin Germany

Division of Viral Transformation Mechanisms German Cancer Research Center Im Neuenheimer Feld 242 69120 Heidelberg Germany Interfaculty Institute of Biochemistry University of Tübingen 72076 Tübingen Germany

Division of Viral Transformation Mechanisms German Cancer Research Center Im Neuenheimer Feld 242 69120 Heidelberg Germany Microbiology School Universidad Industrial de Santander Carrera 27 con calle 9 680 011 Bucaramanga Colombia

Division of Viral Transformation Mechanisms German Cancer Research Center Im Neuenheimer Feld 242 69120 Heidelberg Germany Unit of Microbiology Department of Diagnostic Medicine and Prevention S Orsola Malpighi University Hospital Bologna Italy

Laboratorio de Inmunopatología Instituto de Biología y Medicina Experimental Consejo Nacional de Investigaciones Científicas y Técnicas C1428 Ciudad de Buenos Aires Argentina

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017079
003      
CZ-PrNML
005      
20180517093703.0
007      
ta
008      
180515s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12885-016-2700-8 $2 doi
035    __
$a (PubMed)27558259
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Higareda-Almaraz, Juan Carlos $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany. Institute for Diabetes and Cancer, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), 85764, Neuherberg, Germany.
245    10
$a Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment / $c JC. Higareda-Almaraz, JS. Ruiz-Moreno, J. Klimentova, D. Barbieri, R. Salvador-Gallego, R. Ly, IA. Valtierra-Gutierrez, C. Dinsart, GA. Rabinovich, J. Stulik, F. Rösl, B. Rincon-Orozco,
520    9_
$a BACKGROUND: Galectin-7 (Gal-7) is negatively regulated in cervical cancer, and appears to be a link between the apoptotic response triggered by cancer and the anti-tumoral activity of the immune system. Our understanding of how cervical cancer cells and their molecular networks adapt in response to the expression of Gal-7 remains limited. METHODS: Meta-analysis of Gal-7 expression was conducted in three cervical cancer cohort studies and TCGA. In silico prediction and bisulfite sequencing were performed to inquire epigenetic alterations. To study the effect of Gal-7 on cervical cancer, we ectopically re-expressed it in the HeLa and SiHa cervical cancer cell lines, and analyzed their transcriptome and SILAC-based proteome. We also examined the tumor and microenvironment host cell transcriptomes after xenotransplantation into immunocompromised mice. Differences between samples were assessed with the Kruskall-Wallis, Dunn's Multiple Comparison and T tests. Kaplan-Meier and log-rank tests were used to determine overall survival. RESULTS: Gal-7 was constantly downregulated in our meta-analysis (p < 0.0001). Tumors with combined high Gal-7 and low galectin-1 expression (p = 0.0001) presented significantly better prognoses (p = 0.005). In silico and bisulfite sequencing assays showed de novo methylation in the Gal-7 promoter and first intron. Cells re-expressing Gal-7 showed a high apoptosis ratio (p < 0.05) and their xenografts displayed strong growth retardation (p < 0.001). Multiple gene modules and transcriptional regulators were modulated in response to Gal-7 reconstitution, both in cervical cancer cells and their microenvironments (FDR < 0.05 %). Most of these genes and modules were associated with tissue morphogenesis, metabolism, transport, chemokine activity, and immune response. These functional modules could exert the same effects in vitro and in vivo, even despite different compositions between HeLa and SiHa samples. CONCLUSIONS: Gal-7 re-expression affects the regulation of molecular networks in cervical cancer that are involved in diverse cancer hallmarks, such as metabolism, growth control, invasion and evasion of apoptosis. The effect of Gal-7 extends to the microenvironment, where networks involved in its configuration and in immune surveillance are particularly affected.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a galektiny $x metabolismus $7 D037161
650    _2
$a lidé $7 D006801
650    _2
$a nádorové mikroprostředí $x fyziologie $7 D059016
650    _2
$a nádory děložního čípku $x metabolismus $x patologie $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ruiz-Moreno, Juan S $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany. Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Charité, 10117, Berlin, Germany.
700    1_
$a Klimentova, Jana $u Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defense, 500 01, Hradec Králové, Czech Republic.
700    1_
$a Barbieri, Daniela $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany. Unit of Microbiology, Department of Diagnostic Medicine and Prevention, S. Orsola-Malpighi University Hospital, Bologna, Italy.
700    1_
$a Salvador-Gallego, Raquel $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany. Interfaculty Institute of Biochemistry, University of Tübingen, 72076, Tübingen, Germany.
700    1_
$a Ly, Regina $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany.
700    1_
$a Valtierra-Gutierrez, Ilse A $u Department Biologie II, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
700    1_
$a Dinsart, Christiane $u Division of Tumor Virology, German Cancer Research Center (DKFZ), 69,120, Heidelberg, Germany.
700    1_
$a Rabinovich, Gabriel A $u Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas, C1428, Ciudad de Buenos Aires, Argentina.
700    1_
$a Stulik, Jiri $u Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defense, 500 01, Hradec Králové, Czech Republic.
700    1_
$a Rösl, Frank $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany. f.roesl@dkfz-heidelberg.de.
700    1_
$a Rincon-Orozco, Bladimiro $u Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany. blrincon@uis.edu.co. Microbiology School, Universidad Industrial de Santander, Carrera 27 con calle 9, 680,011, Bucaramanga, Colombia. blrincon@uis.edu.co.
773    0_
$w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 16, č. - (2016), s. 680
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27558259 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517093840 $b ABA008
999    __
$a ok $b bmc $g 1300703 $s 1013919
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 16 $c - $d 680 $e 20160824 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...